SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
PTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading PTX News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.13%22.853.5%$626.74m
SHPGShire PLC Sponsored ADR
-0.62%192.290.4%$315.23m
PRGOPerrigo Co. Plc
0.10%92.553.1%$180.58m
RLYPRelypsa, Inc.
-0.31%31.9727.7%$155.77m
ENDPEndo International Plc
1.20%17.715.6%$135.66m
ICPTIntercept Pharmaceuticals, Inc.
0.19%158.5012.8%$90.25m
JAZZJazz Pharmaceuticals Plc
-0.44%141.343.1%$85.07m
MNKMallinckrodt Plc
0.50%66.829.0%$84.55m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.56%93.207.7%$66.43m
HZNPHorizon Pharma plc
-0.69%18.7311.8%$65.06m
UTHRUnited Therapeutics Corporation
0.65%112.1315.4%$61.45m
SAGESAGE Therapeutics, Inc.
-1.51%43.718.4%$60.42m
ALRAlere Inc.
-0.11%43.914.6%$47.57m
MDCOMedicines Company
0.48%35.3819.2%$37.10m
SGNTSagent Pharmaceuticals, Inc.
-0.09%21.675.9%$36.98m

Company Profile

Pernix Therapeutics Holdings, Inc. is a pharmaceutical company, which is focused on the sales, marketing and development of branded and generic pharmaceutical products for the pediatric market. Its pediatric products are focused on allergy and upper respiratory, including nasal, chest congestion and cough, antibiotics, and dermatology. Pernix Therapeutics Holdings branded products CEDAX, an antibiotic for middle ear infections; NATROBA, which is a topical treatment for head lice; OMECLAMOX-PAK, a ten-day therapy of omeprazole delayed-release capsules, clarithromycin tablets and amoxicillin capsules for the treatment of helicobacter pylori infection and duodenal ulcer disease; and REZYST, which is a probiotic blend to promote dietary management. The company promotes its branded pediatric and generic products through its sales force wholly-owned subsidiary, Macoven Pharmaceuticals. Pernix Therapeutics Holdings was founded in March 9, 2010 and is headquartered in The Woodlands, TX.